1 First Department of Internal Medicine, Kagawa Medical University, Kagawa, Japan
2 Department of Signal Transduction Sciences, Kagawa Medical University, Kagawa, Japan
3 Department of Medicine, Faculty of Medicine, University of Calgary, Health Sciences Center, Calgary, Alberta, Canada
4 Department of Biochemistry & Molecular Biology, Faculty of Medicine, University of Calgary, Health Sciences Center, Calgary, Alberta, Canada
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
The maintenance of blood glucose concentrations within narrow limits is of critical physiologic importance in mammals. Elevated glucose concentrations stimulate the transcription of the insulin and several other genes that regulate glucose homeostasis (1,2). However, the molecular mechanisms by which glucose regulates the transcription of these genes, especially that of insulin, are only partially understood (3).
Although glucose stimulation of insulin biosynthesis at the posttranscriptional and translational level has been studied in detail, the glucose stimulation of insulin gene transcription has not. The exclusive pancreatic islet ß-cell expression of the insulin gene is controlled by cis-acting elements that reside within the 340 to 91 bp of the gene, which interact with selected nuclear factors (4). Studies (5,6) show that sites A3 (201 to 196), C1 (115 to 107), and E1 (100 to 91) are essential for efficient expression of the insulin gene in the ß-cells. Under physiologic conditions, insulin gene transcription is controlled by a glucose concentration through a mechanism that regulates the activity of both C1 and A3 (CT2, Flat-E) cis-acting elements (4).
Intracellular Ca2+ plays an important role in ß-cell function. This ion is the key intracellular mediator of glucose-stimulated insulin secretion (7,8) and directly affects the biosynthesis of insulin (9). In addition, Ca2+ also enhances transcription of the human insulin gene. This effect of calcium is completely blocked by exposure to a Ca2+/calmodulin (CaM)-dependent protein kinase (CaM-K) inhibitor (10) and thus suggests that the actions of calcium on the insulin gene are mediated in part by Ca2+/CaM-Ks. These kinases belong to a diverse group of enzymes that participate in many cellular responses and are activated by increasing concentrations of intracellular Ca2+. There are two multifunctional CaM-Ks, named CaM-KI and -IV, which are activated by an upstream CaM-K kinase (CaM-KK) through phosphorylation of a threonine residue within the active loop of the protein. This phosphorylation strongly upregulates the catalytic activity of both enzymes (11).
Since the CaM-K inhibitor blocked calcium stimulation of insulin gene transcription (10), this finding suggests the participation of CaM-Ks in glucose control of the gene. In addition, previous studies showed that activity of the transcription factor ATF (activating transcription factor)-2, which binds to the human insulin gene for cAMP-responsive elements is enhanced by Ca2+/CaM-KIV (12). These findings pointed to the potential role of CaM-Ks and prompted us to examine whether the CaM-KK/CaM-KIV cascade existed in pancreatic ß-cells. The results of our studies suggest a mechanism requiring the CaM-KK/CaM-KIV cascade in glucose control of insulin gene transcription.
![]() |
RESEARCH DESIGN AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cell culture.
The INS-1 cells originated from a rat insulinoma cell line that was developed and propagated at the Division of Biochimie Cliniqe (courtesy of Dr. C.B. Wollheim, Geneva, Switzerland). The present experiments were performed using cell passages 6172. These cells were cultured in RPMI 1640 media (Gibco, Tokyo, Japan) containing 11.2 mmol/l glucose (unless otherwise stated) and supplemented with 10% heat-inactivated fetal bovine serum (Dainippon Pharmaceutical, Tokyo, Japan), 50 µmol/l 2-mercaptoethanol, 100 units/ml penicillin, and 0.1 mg/ml streptomycin. Islets of Langerhans were isolated from pancreata of 250-g male Sprague-Dawley rats as previously described (15).
PCR.
Total RNA was extracted from the INS-1 and the pancreatic islet cells from Sprague-Dawley rats according to methods described previously (16). The expression of CaM-KIV and CaM-KK was examined using RT-PCR as described previously (16). A primer pair matching the published sequence (17,18) of CaM-KIV and CaM-KK (sense: 5'-GCCCTATGCTCTCAAAGTGT-3' and 5'-GGAGGTGAAGAACTCAGTC-3'; antisense: 5'-CACACCGTCTTCATGAGCAC-3'and 5'-GGATGCAGCCTCATCTTCCT-3', respectively) was used in separate RT-PCRs. Thirty cycles of PCR for CaM-KIV and CaM-KK were carried out using a thermal cycler (Sanko Junyaku, Tokyo, Japan) according to a step program of 60 s at 94°C, 60 s at 51°C, and 60 s at 72°C, followed by a 15-min extension at 72°C. The identity of the PCR-amplified DNA products was confirmed by sequence analysis.
Immunohistochemical localization.
Tissue specimens of interest were fixed in formalin and embedded in paraffin. Sections were incubated overnight with a goat polyclonal antibody directed against CaM-KIV (sc-1546; Santa Cruz Biotechnology, Santa Cruz, CA) or a goat polyclonal antibody directed against CaM-KK (sc-1548; Santa Cruz Biotechnology) in 5% normal rabbit serum in PBS. Sections were rinsed in PBS, incubated for 60 min with a biotinylated antibody (Vectastain Elite kit; Vector Laboratories, Burlingame, CA) in 1% normal rabbit serum in PBS, rinsed in PBS, and incubated with an avidin-biotinylated peroxidase complex (Vectastain Elite kit) in PBS, as recommended by the manufacturer. Antibody binding was visualized with the diaminobenzidine reaction, and sections were counterstained with Mayers hemotoxylin. Double immunofluorescence for insulin and CaM-KK or CaM-KIV was visualized using an indirect immunofluorescence technique. To perform double staining, slides were incubated with a rabbit polyclonal insulin antibody (1:100) mixed with one of the following antisera: goat polyclonal antibody to CaM-KIV (1:100) and goat polyclonal antibody to CaM-KK (1:100). After rinsing in PBS, the sections were incubated with a mixture of rhodamine-conjugated donkey anti-goat immunoglobulins (1:100) and fluorescein-conjugated donkey anti-rabbit antibody (1:100). The processed slides were examined using fluorescence microscopy.
Activation and phosphorylation of CaM-KI by INS-1 cell extract.
GST-CaM-KI (1.0 µg) was incubated with either INS-1 cell extract (2.4 µg) or buffer at 30°C for 20 min in 10 µl of 50 mmol/l HEPES (pH 7.5), 10 mmol/l Mg(Ac)2, 1 mmol/l dithiothreitol, and 400 µmol/l ATP containing either 2 mmol/l CaCl2 or 8 µmol/l CaM. The reaction was terminated by diluting 20-fold at 4°C with 50 mmol/l HEPES (pH 7.5), 2 mg/ml BSA, 10% ethylene glycol, and 2 mmol/l EDTA. CaM-KI activity was measured at 30°C for 10 min in 25 µl of 50 mmol/l HEPES (pH 7.5), 10 mmol/l Mg(Ac)2, 1 mmol/l dithiothreitol, 400 µmol/l [-32P]ATP (1,0002,000 cpm/pmol), and 40 µmol/l syntide-2 containing 2 mmol/l CaCl2/8 µmol/l CaM. The reaction was initiated by the addition of 5 µl CaM-KI and terminated by spotting 15-µl aliquots onto phosphocellulose paper (Whatman P81; Whatman, Kent, U.K.) followed by washing in 75 mmol/l phosphoric acid. Phosphorylation of GST-CaM-KI by INS-1 cell extract was essentially the same as that of the activation assay except for the use of 400 µmol/l [
-32P]ATP (1,0002,000 cpm/pmol). After a 20-min incubation at 30°C, the reaction was terminated by adding 5 µl of SDS-PAGE sample buffer. Then the samples were subjected to SDS-10%PAGE, followed by autoradiography.
CaM-KIV activity in INS-1 cells.
The day before testing, the INS-1 cells were incubated overnight with regular medium containing 2.8 mmol/l glucose. INS-1 cells were treated with 11.2 mmol/l glucose for 1 min before harvest at indicated time periods, and then the cells were lysed and endogenous CaM-KIV was immunoprecipitated with anti-CaM-KIV antibody (an affinity-purified goat polyclonal antibody, sc-1546; Santa Cruz Biotechnology). CaM-KIV activity in the immunocomplex was measured at 30°C for 10 min in 30 µl of 50 mmol/l HEPES (pH 7.5), 10 mmol/l Mg(Ac)2, 1 mmol/l dithiothreitol, 400 µmol/l [-32P]ATP (1,0002,000 cpm/pmol), and 40 µmol/l syntide-2 containing 2 mmol/l CaCl2/8 µmol/l CaM.
Transfection of INS-1 cells and luciferase reporter gene assay.
The reporter gene used in our studies was kindly provided by Dr. Roland Stein (Vanderbilt University Medical Center, Nashville, TN). The wild type (238 WT-LUC) contains the rat insulin-2 gene sequences spanning the region from 238 to 2 bp that are linked to the luciferase reporter gene. Purified reporter plasmid was transfected into INS-1 (at 60% confluence) using a conventional cationic liposome transfection method (lipofectamine; Life Technologies, Gaithersburg, MD). All assays were corrected for ß-galactosidase activity, and total amounts of protein per reaction were identical (16). Both cDNA of Ca2+/CaM-independent mutant of CaM-KIV (CaM-KIVc, 305 HMDT to DEDD), CaM-KIV kinase-negative mutant (CaM-KIVdn, 305 HMDT to DEDD, K71E), and CaM-KK mutant (CaM-KKc, residues 1434) were constructed as described previously (19,20). Transfected cells were harvested, and ß-galactosidase activity was measured in an aliquot of the cytoplasmic fraction (16). Twenty-microliter aliquots were taken for the luciferase assay and performed according to the manufacturers instructions (ToyoInk, Tokyo, Japan).
Expression of CaM-KIV mutants in INS-1 cells using recombinant adenovirus infection.
Recombinant adenoviruses carrying cDNAs of CaM-KIV were produced using the Adeno-X Expression System (Clontech, Palo Alto, CA) as previously described (21,22). For virus infection, confluent INS-1 cells in six-well culture plates were infected with viruses at a multiplicity of infection of 20 plaque-forming units/cell at 37°C for 1 h. After infection, viruses were aspirated and cells were further cultured in RPMI medium containing 10% fetal bovine serum. The insulin gene expression and insulin secretion were determined by Northern blot analysis and enzyme immunoassay.
Northern blot analysis.
A single-step acid guanidinium thiocyanate-phenol-chloroform extraction technique was used to isolate total RNA from INS-1 cells transfected with adenovirus carrying cDNA of CaM-KIVc or CaM-KKc + CaM-KIVc as described previously (22). Separation of the RNA samples, transfer to membrane, and hybridization with the insulin probe was described previously (23). To detect rat insulin mRNA, we used a 355-bp probe derived from INS-1 cDNA obtained using PCR amplification using insulin-specific oligonucleotide primers. The rat insulin sense and antisense primers were 5'-ATAGACCATCAGCAAGCAGG-3' and 5'-CTCCAGTTGTGGCACTTGCG-3', respectively (24). Probes used in the hybridization were labeled with digoxigenin (Boehringer Mannheim, Indianapolis, IN) using nick translation and then purified as previously described (24). Blots were also probed with rat ß-actin to assess equal loading of samples (24). After posthybridization washes, the membranes were incubated with anti-Dig antibody (Boehringer Mannheim), followed by treatment with AMPPD, and then exposed to X-ray film for 1545 min.
Insulin enzyme-linked immunosorbent assay.
The levels of immunoreactive insulin were quantified using a commercially available sandwich-type enzyme-linked immunosorbent assay (ELISA) (Shibayagi, Tokyo, Japan). This ELISA is sensitive to 1 ng/ml insulin, and it has an intra-assay coefficient of variation of <0.5% and an interassay coefficient of variation of <10%.
Others.
Western blotting was carried out using either anti-CaM-KK antibody (Transduction Laboratories, Lexington, KY) or anti-CaM-KIV antibody (Transduction Laboratories). Detection was performed by using chemiluminescence reagent (NEN Life Science Products, Boston, MA).
Statistical analysis.
Statistical comparisons were made by one-way ANOVA and Students t test, with P < 0.05 considered significant.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Next, we wondered whether the CaM-KK in the cells was functionally active. To address this question, we added recombinant CaM-KI to extract from INS-1 cells for 20 min in the presence of Mg-ATP and Ca2+/CaM and measured both protein kinase activity and [32P] incorporation of GST-CaM-KI. Results (Fig. 2B) showed a dramatic upregulation of the catalytic activity of GST-CaM-KI that was 10-fold higher than control as well as upregulation of [32P] incorporation into GST-CaM-KI. Previous studies demonstrated that CaM-KK activated both CaM-KI and CaM-KIV through phosphorylation of a Thr residue (Thr196 in CaM-KIV and Thr177 in CaM-KI). To show that CaM-KK activity in INS-1 extract activates GST-CaM-KIV via the same mechanism, we added to the reaction a mutant GST-CaM-KI that contains a Thr177Ala substitution. As predicted, phosphorylation and activation of the mutant GST-CaM-KI by INS-1 cell extract was not observed. These results clearly demonstrate that INS-1 cell extract contains both CaM-KK and CaM-KIV.
Effect of CaM-K cascade on insulin gene transcription.
Previous studies (10,12) showed that secreted insulin may upregulate insulin gene transcription via signaling through activation of CaM-KIV. However, whether the CaM-K cascade is a part of this process is not known. Published evidence (25) supports a role for CaM-KIV in transcriptional regulation, and because this kinase is activated by CaM-KK, it is likely that this upstream kinase is also involved. Therefore, we examined the potential role of the CaM-K cascade by cotransfecting INS-1 cells with 238 WT-LUC plus CaM-KIV and/or CaM-KK to determine whether these latter proteins affected insulin gene transcription. Results (Fig. 3) showed that constitutively active CaM-KIV (CaM-KIVc) alone stimulated a sixfold increase in insulin promoter activity in INS-1 cells. Furthermore, the introduction of nonactivated wild-type CaM-KIV along with constitutively active CaM-KK (CaM-KKc) caused a seven- to eightfold increase in transcriptional activation of insulin gene. In contrast, the cotransfection of nonactivated wild-type CaM-KIV and wild-type CaM-KK did not activate the reporter pINS-LUC (Fig. 3, last column).
|
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Previous reports (12) showed that CaM-KIV was expressed in pancreatic islet and other insulin-secreting cells, including MIN6 and HIT cells. In the first set of studies, we established that the respective mRNAs encoding CaM-KIV and its upstream protein kinase, CaM-KK, were present in rat pancreatic islet and the insulin-secreting cell line, INS-1. Furthermore, the mRNA was expressed because both Western blot and immunohistochemistry of the cells showed the presence of the protein products in the cells. The expression of these genes does not reveal any information regarding its function in the cell. The possible existence of a short-term effect of glucose on insulin gene transcription was suggested indirectly, but as yet has never been clearly shown by previous reports (27,28). The results of Efrat et al. (29) clearly demonstrated that increased levels of nuclear insulin mRNA can be detected in ßTC-3 cells as early as 10 min after glucose stimulation. Similar dynamics obtained in the previous study (30), when analyzing transcription initiation in HIT cells after a 15-min glucose stimulus on top of a 0.1-mmol/l glucose background, support these earlier findings. These data clearly demonstrate a short-term regulation of insulin gene transcription by glucose. We showed here that the enzyme activity of CaM-KIV was elevated within 2 min by glucose stimulation and that activated CaM-KK/CaM-KIV cascade stimulated the insulin transcription. Additionally, CaM-KIVdn prevented the activation of insulin transcription by glucose stimulation; therefore, not only CaM-KIV but also CaM-KK/CaM-KIV cascade might participate in glucose-stimulated insulin gene transcription. Recently, Leibiger et al. (10) reported that secreted insulin in response to glucose stimulation is a key factor in glucose-stimulated insulin gene transcription. On the other hand, several studies have indicated that glucose can also regulate the insulin gene independently of insulin secretion (30,31); furthermore, insulin gene expression appears to be largely unaltered after targeted disruption of the insulin receptor gene in the islet ß-cell, at least in younger animals (32). Although the possibility that secreted insulin in response to glucose stimulation may activate the insulin gene transcription cannot be excluded at this point, we found that in our in vitro study with INS-1 cells, glucokinase, a key enzyme of glucose metabolism in the pancreatic ß-cell, was regulated by CaM-KK/CaM-KIV cascade (Y.S., K.M., unpublished data). The role of the CaM-KK/CaM-KIV cascade in insulin synthesis as well as in glucose metabolism in pancreatic ß-cells deserves further investigation.
One of the most common mechanisms by which elevated intracellular Ca2+ regulates cellular events is through its association with CaM. The Ca2+/CaM complex binds to and modulates the functions of multiple key regulatory proteins, including a family of CaM-Ks (33). A role for transcriptional regulation by CaM-K is suggested by the observation that the Ca2+-dependent transcription of three immediate early genes (c-fos, NGFI-A, and NGFI-B) was 80% blocked by the CaM-K inhibitor, KN-62 (25). CaM-KK has been identified and cloned as an activator for two multifunctional CaM-KKs, CaM-KI and -IV. Phosphorylation by CaM-KK of Thr, located in the activation loop of the catalytic domain of CaM-KIV, results in a large increase in the catalytic efficiency of CaM-K (20,34). Numerous studies have demonstrated that the CaM-KK/CaM-KIV cascade is present and functional in various cell types, such as the Jurkat cell (26), cultured hippocampal neurons (35), and transfected COS-7 cells (19). We showed that both pancreatic ß-cells and the insulin-secreting cell line, INS-1, have this signal cascade. CaM-KIV, which has significant nuclear localization (36), phosphorylates transcription factors such as cAMP-responsive element binding protein (CREB) and serum response factor (37). Several studies have shown that CaM-KIV can mediate transcriptional stimulation through CREB phosphorylation (38,39). More recently, we have demonstrated (34) that cotransfection of nonactivated wild-type CaM-KIV with CaM-KKc stimulates CREB-mediated transcription 14-fold relative to either kinase alone. This is consistent with the in vitro observation that the Vmax-to-Km ratio of CREB phosphorylation was increased 30-fold by activation of CaM-KIV by CaM-KK (40). The promoter region of the insulin gene has been cloned, sequenced, and shown to contain putative consensus binding sites for a variety of transcription factors. The insulin promoter contains several cis-acting regulatory elements located within the 5' flanking region. These elements interact with transacting factors. Some of these factors are found ubiquitously, whereas others are more restricted to the ß-cell. Important transcriptional regulatory elements have been identified in the promoter regions of the insulin gene; two of the more important elements are the A3 and C1 (46). It is well known that glucose increases the concentration of both cAMP and Ca2+ in pancreatic ß-cells (7) and triggers insulin secretion from pancreatic ß-cells. In rat primary cultured islets, ATF-2 (also called CREBP1) increased the glucose-upregulated activities of the human insulin promoter (12). ATF-2 was originally isolated as a protein binding to cAMP response elements (41) and belongs to the CREB/ATF family characterized by kination and basic leucine zipper DNA-binding domains, which is consistent with the previous report (42) that ATF-2 is a target of JNK and p38 MAP kinase. ATF-2 is capable of forming homodimers or heterodimers with c-Jun and of binding to cAMP response elements, including the promoter region in the human insulin gene (43). The transcription of the human insulin gene, enhanced by an elevated intracellular concentration of calcium ions, was completely blocked by Ca2+/CaM-K inhibitor (10). The activity of the transcription factor ATF-2, which binds to the cAMP responsive elements of the human insulin gene, was enhanced by CaM-KIV, but CaM-KII or protein kinase A has no effect on ATF-2 activity (12). Further investigation will be needed to clarify the mechanism of the CaM-KK/CaM-KIV cascade on insulin gene transcription.
In summary, we examined the role of the CaM-KK/CaM-KIV cascade on insulin gene expression in response to glucose stimulation in the insulinoma cell line. The results indicate that the CaM-KK/CaM-KIV cascade stimulated insulin gene transcription, suggesting that the activation of the CaM-KK/CaM-KIV cascade may play an important role in insulin biosynthesis in pancreatic ß-cells.
![]() |
ACKNOWLEDGMENTS |
---|
We thank Kazuko Yamaji and Kiyo Ueeda for their technical assistance.
Address correspondence and reprint requests to Koji Murao, MD, PhD, First Department of Internal Medicine, Kagawa Medical University, 1750-1, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. E-mail: mkoji{at}kms.ac.jp
Received for publication May 31, 2003 and accepted in revised form March 15, 2004
ATF, activating transcription factor; CaM, calmodulin; CaM-K, CaM-dependent protein kinase; CaM-KIVc, constitutively active CaM-KIV; CaM-KIVdn, dominant-negative mutant of CaM-KIV; CaM-KK, CaM-K kinase; CaM-KKc, constitutively active CaM-KK; CREB, cAMP-responsive element binding protein; ELISA, enzyme-linked immunosorbent assay; GST, glutathione S-transferase
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum | DOC News |